Company / Interest Expense per Share
Immunovant, Inc. Interest Expense per Share History
FY2019-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense per Share
$0.18
FY2023
5-year range
$0.00 / $0.18
FY2019-FY2023
Trend
+193.4%
vs FY2022
Sector context
#22 of 41
Health Care
What the data says
At $0.18, Immunovant, Inc.'s interest expense per share ranks #20 of 41 in the Health Care sector. Increased from $0.00 to $0.18 over the past 2 years.
Based on SEC 10-K filings.
0.18 in FY2023.
Increased from $0.00 to $0.18 over the past 2 years.
Health Care sector context is included.
Interest Expense per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#20 of 41 in Health CareTop 46% of 41This company $0.18 Sector average $10.31
▼
-98.2% below sector average
Key checks
Key Insights
- In FY2023, interest expense per share increased 193.4% year-over-year.
- Ranks #22 out of 41 companies in the Health Care sector.
- Lowest interest expense per share in the period was in FY2021.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest Expense per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | - | - |
| FY2023 | $0.18 | +193.4% |
| FY2022 | $0.06 | - |
| FY2021 | $0.00 | - |
| FY2020 | $0.00 | -100.0% |
| FY2019 | $0.01 | - |
| FY2018 | - | - |
As of FY2023 · SEC 10-K · Updated Feb 28, 2026